Condition: Cardiogenic Shock Post Myocardial Infarction · Sponsor: University Hospital of Cologne
The aim of this trial is to evaluate whether a structured and time-optimized escalation strategy from a transfemoral microaxial flow-pump (Impella CP™) to the Impella 5.5™ microaxial flow-pump is associated with improved clinical outcomes and fewer adverse events in patients with cardiogenic shock due to acute myocardial infarction
This description comes directly from the study's public registry record.
Sebastian Heyne, Dr. med. · +4915125364083 · sebastian.heyne@uk-koeln.de
Always discuss trial participation with your own doctor first.
| University Hospital Cologne | Cologne, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07655479